Relationship between inflammation biomarkers, antioxidant vitamins, and bone mineral density in patients with metabolic syndrome
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Few studies have shown the correlation between metabolic syndrome and bone mineral density (BMD). The main pathogenic mechanisms of metabolic syndrome rely on chronic low-level inflammatory status and oxidative stress. There are few studies that examine the gender-specific effects of inflammation and antioxidants on BMD. In this study, we evaluated the relative contribution of these factors in patients with metabolic syndrome. We conducted a cross-sectional study of 67 men and 46 postmenopausal women with metabolic syndrome; metabolic syndrome was defined as having three or more metabolic syndrome risk factors. BMD, body fat mass, and lean body mass were evaluated. We also examined the levels of high sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), adiponectin, vitamin E, and C in serum. Log-transformed hs-CRP levels were significantly higher in lumbar spine osteoporotic subjects than in normal subjects for women but not for men. There was no significant difference between the normal group and the osteoporotic group in other inflammatory markers. Stepwise regression analyses for BMD of the lumbar spine showed that lean body mass and vitamin E were significant determinants in men. Lean body mass and log-transformed hs-CRP were significant determinants in women Analysis for BMD of the femoral neck showed that lean body mass was a significant determinant for both men and women. There was no significant factor among the inflammatory markers or antioxidant vitamins affecting the femoral neck BMD for either gender. In conclusion, while hs-CRP is an independent predictor of the BMD of the lumbar spine in women, vitamin E showed profound effects on BMD in men but not women with metabolic syndrome.
Abstract
Few studies have shown the correlation between metabolic syndrome and bone mineral density (BMD). The main pathogenic mechanisms of metabolic syndrome rely on chronic low-level inflammatory status and oxidative stress. There are few studies that examine the gender-specific effects of inflammation and antioxidants on BMD. In this study, we evaluated the relative contribution of these factors in patients with metabolic syndrome. We conducted a cross-sectional study of 67 men and 46 postmenopausal women with metabolic syndrome; metabolic syndrome was defined as having three or more metabolic syndrome risk factors. BMD, body fat mass, and lean body mass were evaluated. We also examined the levels of high sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), adiponectin, vitamin E, and C in serum. Log-transformed hs-CRP levels were significantly higher in lumbar spine osteoporotic subjects than in normal subjects for women but not for men. There was no significant difference between the normal group and the osteoporotic group in other inflammatory markers. Stepwise regression analyses for BMD of the lumbar spine showed that lean body mass and vitamin E were significant determinants in men. Lean body mass and log-transformed hs-CRP were significant determinants in women Analysis for BMD of the femoral neck showed that lean body mass was a significant determinant for both men and women. There was no significant factor among the inflammatory markers or antioxidant vitamins affecting the femoral neck BMD for either gender. In conclusion, while hs-CRP is an independent predictor of the BMD of the lumbar spine in women, vitamin E showed profound effects on BMD in men but not women with metabolic syndrome.
참고문헌 (41)
- Isomaa B, "Cardiovascular morbidity and mortality associated with the metabolic syndrome", Diabetes Care, 24, pp.683~689 (2001)
- Lakka HM, "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men", JAMA, 288, pp.2709~2716 (2002)
- National Cholesterol Education Program (NCEP) Expert panel on Detection, "Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report", Circulation, 106, pp.3143~3421 (2002)
- Korea National Health and Nutrition Examination Survey Report (KNHANES III)- Health Examination, "Ministry of Health and Welfare (MOHW)", Ministry of Health and Welfare (MOHW), ~ (2005)
- 김진화, "당뇨병이 없는 성인에서 심혈관질환 위험요소 및 대사증후군과 당화혈색소의 상관관계", Diabetes and Metabolism Journal, 32(5), pp.435~444 (2008), 대한당뇨병학회
- Wellen KE, "Inflammation, stress, and diabetes", J Clin Invest, 115, pp.1111~1119 (2005)
- Luc G, "C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study", Arterioscler Thromb Vasc Biol, 23, pp.1255~1261 (2003)
- Furukawa S, "Increased oxidative stress in obesity and its impact on metabolic syndrome", J Clin Invest, 114, pp.1752~1761 (2004)
- Ford ES, "The metabolic syndrome and antioxidant concentrations", Diabetes, 52, pp.2346~2352 (2003)
- Palmieri VO, "Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome", J Nutr, 136, pp.3022~3326 (2006)
- Yamaguchi T, "Plasma lipids and osteoporosis in postmenopausal women", Endocr J, 49, pp.211~217 (2002)
- Cui LH, "Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea", Osteoporos Int, 16, pp.1975~1981 (2005)
- von Muhlen D, "Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study", Osteoporos Int, 18, pp.1337~1344 (2007)
- 강영한, "건강검진 수진자들에서 골밀도와 대사증후군의 연관성", 방사선기술과학, 31(3), pp.259~266 (2008), 대한방사선과학회
- Kim HY, "Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men", Calcif Tissue Int, 86, pp.350~358 (2010)
- Oh KW, "Diabetes and osteoporosis", Korean J Bone Metab, 15, pp.91~98 (2008)
- Lazarenko OP, "Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone", Endocrinology, 148, pp.2669~2680 (2007)
- Sorocéanu MA, "Rosiglitazone impacts negatively on bone by promoting osteoblast", osteocyte apoptosis, 2004, pp.183, 203~216
- Lara-Castro C, "Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease", Curr Opin Lipidol, 18, pp.263~270 (2007)
- Yamaguchi N, "Adiponectin inhibits induction of TNF-alpha", RANKL-stimulated NFATc1 via the AMPK signaling, 2008, pp.582, 451~456
- Feingold KR, "Role of cytokines in inducing hyperlipidemia", Diabetes, 41, pp.97~101 (1992)
- Hotamisligil GS, "Tumor necrosis factor alpha inhibits signaling from the insulin receptor", Proc Natl Acad Sci U S A, 91, pp.4854~4858 (1994)
- Ridker PM, "High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease", Circulation, 103, pp.1813~8. (2001)
- Whitcomb BW, "C-reactive protein levels are associated with decreased bone mineral density in Mexican Americans", J Bone Miner Res, 19, pp.289~ (2004)
- Bae SJ, "Higher circulating hs-CRP levels are associated with lower bone mineral density in healthy premenopausal and postmenopausal women: evidence for link between systemic inflammation and osteoporosis", Korean J Bone Metab, 11, pp.147~157 (2004)
- Kim BJ, "Relationship between bone turnover rate and a systemic inflammatory marker in Korean women", Korean J Bone Metab, 13, pp.129~138 (2006)
- Alberti KG, "Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series, "World Health Organization", Geneva: WHO, ~ (1994)
- Bieri JG, "Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography", Am J Clin Nutr, 32, pp.2143~2149 (1979)
- Kutnink MA, "An internal standard method for the unattended high-performance liquid chromatographic analysis of ascorbic acid in blood components", Anal Biochem, 166, pp.424~430 (1987)
- Nishida M, "Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis", Clin Chim Acta, 384, pp.99~104 (2007)
- Koh JM, "Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis", Osteoporos Int, 16, pp.1263~1271 (2005)
- Kinjo M, "Bone Mineral Density in adults with the Metabolic Syndrome: analysis in a populationbased U.S. Sample", J Clin Endocrinol Metab, 92, pp.4161~4164 (2007)
- McLean RR, "No link between C-Reactive Protein (CRP) and Bone Mineral Density (BMD) in men, but menopause status modifies the relation in women: The Framingham Osteoporosis Study", Arthritis Rheum, 60(10), pp.1131~ (2009)
- Scheidt-Nave C, "Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause", J Clin Endocrinol Metab, 86, pp.2032~2042 (2001)
- Richards JB, "Serum adiponectin and bone mineral density in women", J Clin Endocrinol Metab, 92, pp.1517~1523 (2007)
- Zoico E, "Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate", J Endocrinol Invest, 31, pp.297~302 (2008)
- Russell M, "Visceral fat is a negative predictor of bone density measures in obese adolescent girls", J Clin Endocrinol Metab, 95, pp.1247~1255 (2010)
- Kim CJ, "Relationship between body composition and metabolic bone disease in Korean male adults", Korean J Bone Metab, 15, pp.25~32 (2008)
- Miller ER 3rd, "Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality", Ann Intern Med, 142, pp.37~46 (2005)
- 임윤숙, "Alpha-Tocopherol Transfer Protein (α-TTP): Insights from Alpha-Tocopherol Transfer Protein Knockout Mice", Nutrition Research and Practice, 1(4), pp.247~253 (2007), 한국영양학회